Feedstuffs is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CycleGuard 500 receives medicated feed combination approvals

Six Blue Bird combinations now available for feedlot settings.

CycleGuard 500, a melengestrol acetate feed additive used for increased rate of weight gain, improved feed efficiency and suppression of estrus (heat) in heifers, has received U.S. Food & Drug Administration approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds.

Available as a Type A liquid medicated article from Huvepharma, CycleGuard 500 must be mixed with other feeds when fed, and should be fed according to label directions. The combination approvals, or Blue Bird labels, allow CycleGuard 500 to also be used with other feed additives commonly fed to feedlot cattle to enhance rate of gain, feed efficiency, promote carcass leanness, and control coccidiosis, including monensin, tylosin, ractopamine hydrochloride, and more.

The CycleGuard 500 combinations receiving FDA approval include CycleGuard 500 and Monovet 90; CycleGuard, with Monovet 90 and Optigrid 45; CycleGuard, with Monovet 90 and Tylovet 100; CycleGuard with Monovet 90, Tylovet 100 and Optigrid 45, as well as CycleGuard with Optigrid 45 and Monovet 90 plus and CycleGuard with Optigrid 45, Monovet 90 and Tylovet 100. 

“Huvepharma is focused on offering quality product choices and technical expertise to livestock producers and feeders to aid the industry in enhancing production and efficiency. CycleGuard 500 used with these combination approvals provides one more tool available toward that effort,” said J. Free, director of U.S. Cattle Business for Huvepharma.

Huvepharma has offered animal health products for poultry, swine and cattle in the U.S. since 2005. In addition to CycleGuard 500, over the past eighteen months, the company has received FDA approvals for Monovet 90, the first available bio-equivalent monensin, and Optigrid 45, comprised of the active ingredient ractopamine hydrochloride. 

Huvepharma also recently received FDA approval for four Blue Bird label combinations with Optigrid 45, a ractopamine hydrochloride Type A medicated article used increased rate of weight gain, improved feed efficiency, and increased carcass leanness in cattle fed in confinement for slaughter. 

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.